CIENCIASMEDICASNEWS: Cancer Cell International

domingo, 13 de enero de 2019

Articles

Content Type:Primary Research
| 11 January 2019
Rosiglitazone metformin adduct inhibits hepatocellular carcinoma proliferation via activation of AMPK/p21 pathway
Authors:Yuyang Liu, Xiangnan Hu, Xuefeng Shan, Ke Chen and Hua Tang
Content Type:Review
| 8 January 2019
CRISPR–Cas9 a boon or bane: the bumpy road ahead to cancer therapeutics
Authors:Debarati Ghosh, Prabhadevi Venkataramani, Saikat Nandi and Sonali Bhattacharjee
Content Type:Primary Research
| 8 January 2019
Overexpression of chloride channel-3 (ClC-3) is associated with human cervical carcinoma development and prognosis
Authors:Yu-tao Guan, Yong Xie, Hui Zhou, Hai-yan Shi, Yu-yuan Zhu, Xiao-lu Zhang, Yi Luan, Xi-ming Shen, Yang-ping Chen, Li-jiang Xu, Zhong-qiu Lin and Gang Wang
Content Type:Primary Research
| 8 January 2019
Markers of MEK inhibitor resistance in low-grade serous ovarian cancer: EGFR is a potential therapeutic target
Authors:Marta Llaurado Fernandez, Amy Dawson, Joshua Hoenisch, Hannah Kim, Sylvia Bamford, Clara Salamanca, Gabriel DiMattia, Trevor Shepherd, Mattia Cremona, Bryan Hennessy, Shawn Anderson, Stanislav Volik, Colin C. Collins, David G. Huntsman and Mark S. Carey
Content Type:Primary Research
| 8 January 2019
Genetic polymorphisms of estrogen receptor genes are associated with breast cancer susceptibility in Chinese women
Authors:Zhijun Dai, Tian Tian, Meng Wang, Tielin Yang, Hongtao Li, Shuai Lin, Qian Hao, Peng Xu, Yujiao Deng, Linghui Zhou, Na Li and Yan Diao